Development of small molecule drugs for the treatment of neuropsychiatric and cancer diseases

Development of small molecule drugs for the treatment of neuropsychiatric and cancer diseases

博士 === 臺北醫學大學 === 藥學系(碩博士班) === 107

Bibliographic Details
Main Authors:	Liang-Chieh Chen, 陳亮傑
Other Authors:	Wei-Jan Huang
Format:	Others
Language:	zh-TW
Published:	2019
Online Access:	http://ndltd.ncl.edu.tw/handle/8uaqwz

Similar Items

Small Molecule Modulators of the Circadian Molecular Clock With Implications for Neuropsychiatric Diseases
by: Hyo Kyeong Cha, et al.
Published: (2019-01-01)

Small Molecules: Therapeutic Application in Neuropsychiatric and Neurodegenerative Disorders
by: Stefania Schiavone, et al.
Published: (2018-02-01)

Development of a small molecule drug delivery vehicle for treatment of chronic pulmonary diseases
by: Lofton, Megan Christina
Published: (2008)

Small Molecule Drugs in Inflammatory Bowel Diseases
by: Inès Ben Ghezala, et al.
Published: (2021-06-01)

Inflammation in neuropsychiatric disease
by: Malú G. Tansey
Published: (2010-03-01)

Biomarkers in neuropsychiatric diseases
by: Un Jung Kang
Published: (2009-08-01)

Drug Repurposing Is a New Opportunity for Developing Drugs against Neuropsychiatric Disorders
by: Hyeong-Min Lee, et al.
Published: (2016-01-01)

Neuropsychiatric manifestations of Fahr′s disease pathogenesis and potential for treatment
by: Raheel Mushtaq, et al.
Published: (2013-01-01)

The Emergent Role of Virtual Reality in the Treatment of Neuropsychiatric Disease
by: Yacine Benyoucef, et al.
Published: (2017-09-01)

The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease
by: Holmes, C., et al.
Published: (2004)

The development of small molecule transmembrane anion transporters for the treatment of disease
by: Moore, Stephen J.
Published: (2012)

Small-Molecule Amyloid Beta-Aggregation Inhibitors in Alzheimer's Disease Drug Development
by: Sharmin Reza Chowdhury, et al.
Published: (2019-08-01)

Develop of Potential Small Molecule Therapeutic Agents for the Treatment of Alzheimer's Disease
by: Feng I Chu, et al.
Published: (2002)

Known drugs and small molecules in the battle for COVID-19 treatment
by: Alexios A. Panoutsopoulos
Published: (2020-12-01)

Pharmacogenomics: An Update on Biologics and Small-Molecule Drugs in the Treatment of Psoriasis
by: Valerio Caputo, et al.
Published: (2021-09-01)

Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations
by: Yana Zorkina, et al.
Published: (2020-11-01)

The development of small molecule inhibitors for fibrosis drug discovery
by: Miller, Lisa Margaret
Published: (2016)

A STRATEGY FOR DEVELOPING NEW TREATMENT PARADIGMS FOR NEUROPSYCHIATRIC AND NEUROCOGNITIVE SYMPTOMS IN ALZHEIMER’S DISEASE
by: Hugo eGeerts, et al.
Published: (2013-04-01)

Human-Induced Pluripotent Stem Cells and Herbal Small-Molecule Drugs for Treatment of Alzheimer’s Disease
by: Wei Wuli, et al.
Published: (2020-02-01)

Oligodendroglial Heterogeneity in Neuropsychiatric Disease
by: Sunniva M. K. Bøstrand, et al.
Published: (2021-02-01)

Neuropsychiatric manifestations in autoimmune diseases
by: Simone Appenzeller
Published: (2016-06-01)

Neuropsychiatric symptoms and celiac disease
by: Urban-Kowalczyk M, et al.
Published: (2014-10-01)

Epigenomic Imaging of Neuropsychiatric Diseases
by: Bahari Javan, Sanaz
Published: (2013)

Neuropsychiatric phenotype in Darier's Disease
by: Gordon-Smith, Katherine Mary
Published: (2008)

Mitochondrial trafficking in neuropsychiatric diseases
by: Samineh Deheshi, et al.
Published: (2013-03-01)

Introduction: Epigenetics and neuropsychiatric diseases
by: Mark F. Mehler
Published: (2010-07-01)

Computer-aided drug discovery of novel drugs for neuropsychiatric disorders: Alzheimer’s disease, transthyretin amyloidosis and depression
by: Zhen-Li Zhou, et al.
Published: (2014)

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Progress in Small Molecule Drug Development
by: Praveen P. N. Rao, et al.
Published: (2010-05-01)

20 Diagnosis and treatment of neuropsychiatric lupus
by: Marcello Govoni
Published: (2020-09-01)

Integrated Computational Drug Discovery Approaches for Neuropsychiatric Disorders
by: Zhou, Mengshi
Published: (2020)

Structure-Based Drug Design of Small Molecule Peptide Deformylase Inhibitors to Treat Cancer
by: Jian Gao, et al.
Published: (2016-03-01)

Cognitive and neuropsychiatric disorders in extrapyramidal diseases
by: O. S. Levin, et al.
Published: (2014-01-01)

Neuropsychiatric Disorders in Chronic Kidney Disease
by: Ana Cristina Simões e Silva, et al.
Published: (2019-08-01)

Liver Transplantation for Neuropsychiatric Wilson Disease
by: Narmin Kassam, et al.
Published: (1998-01-01)

Gene expression data and neuropsychiatric disease
by: Richards, Alexander
Published: (2010)

NEUROTRANSMITTER AND RECEPTOR ALTERATIONS IN NEUROPSYCHIATRIC DISEASES
by: Wastek, Gregory John, 1947-
Published: (1978)

Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics
by: Ping Li, et al.
Published: (2017-07-01)

Research Progress of Small Molecule Anti-angiogenic Drugs  in Non-small Cell Lung Cancer
by: Yan DOU, et al.
Published: (2021-01-01)

Novel small molecule EGFR inhibitors as candidate drugs in non-small cell lung cancer
by: Berardi R, et al.
Published: (2013-05-01)

Human platelet monoamine uptake in some neuropsychiatric diseases, and the influence of some centrally acting drugs
by: Ehsanullah, R. S. B.
Published: (1979)

Cannot write session to /tmp/vufind_sessions/sess_9d039rt048u6g8acf6atfgtuun